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Background: The influence of gender in the clinical expression of COPD has received important
attention. Limited information exists regarding gender differences in the skeletal muscle char-
acteristics in COPD subjects. The present study was aimed to determine the differences in the
skeletal muscle characteristics in men and women with and without COPD.
Methods: For comparison we studied 24 female (61  9 years) and 30 male (65  8 years) COPD
patients with similar disease severity. In addition healthy subjects, 17 women (58  8 years),
and 9 men (57  8 years) were studied. Pulmonary function, health status, six minute walk
distance test (6MWD) and vastus lateralis muscle biopsy were assessed. Fiber type proportion,
fiber type cross sectional area (CSA), capillary counts, and activity of citrate synthase (CS),
3-hydroxyacyl-CoA-dehydrogenase (HAD) and lactate-dehydrogenase (LDH) were determined.
Results: Pulmonary function, health status and 6MWD were similar in male and female COPD
patients. Fiber type distribution was similar between women (I Z 42  9%, IIA Z 39  13%,
IIX Z 19  7%) and men (I Z 39  13%, IIA Z 38  9%, IIX Z 29  10%) with COPD, as well
as CSA, capillarity and enzymes (CS 8.59  1.6 vs.9.74  2.6, HAD 9.03  1.9 vs.
9.84  2.5, LDH 124  48 vs. 151  68 mmol min1 g1). In normal subjects a decrease in type
IIX fibers CSA was found in women compared with men (3703  1478 vs. 5426  1386 mm2,
respectively).Medicina Experimental. Apdo. 50587 Sabana Grande, Caracas 1050, Venezuela. Tel.: þ58 2126053382;
il.com (S.H. Torres).
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Gender and muscle characteristics in COPD 89Conclusions: Female and male with COPD have similar skeletal muscle characteristics; it is
possible that the disease blurs the gender differences. On the other hand, there seems to
be fewer differences in muscle characteristics between older men and women, perhaps due
to lower male testosterone levels and physical inactivity.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
The influence of gender in the clinical expression of COPD
has received important attention in the past decade. In
general women with COPD report worse symptoms (in
particular dyspnea), have lower exercise capacity, worse
health related quality of life (HRQoL), and more anxiety
and depression, but apparently lower all-cause and respi-
ratory mortality rates.1e3
On the other hand, skeletal muscle dysfunction is
commonly found in patients with COPD, and is associated
with exercise intolerance, daily activities limitation,
impaired HRQoL, health care resources utilization and
increased mortality.4e7 It is possible that gender differ-
ences in the skeletal muscle function and structure could
explain in part some of the differences described between
men and women. However, muscle characteristics have not
been assessed in many women affected by COPD,8 and most
studies have pooled the female results with those of men
assuming no gender differences.9,10
In healthy subjects there are some gender differences in
the skeletal muscle features. Although an extensive study
reported a lower proportion of type I fibers in the female
quadriceps muscles,11 other studies have not found gender
differences in the proportion of major skeletal muscle fiber
types.12e14 In young subjects, the cross sectional area (CSA)
of the three major fiber types was larger in men compared
to women12e14 and the area occupied by each specific fiber
type was IIA > I > IIB for men and I > IIA > IIB for women.13
Difference in the CSA has also been reported in subjects 50
years and over,14 whereas others have reported only
decreased CSA of the type IIA fibers in older women.15
To our knowledge there is limited information available
regarding gender differences in the skeletal muscle histo-
chemical and metabolic characteristics in subjects with
COPD, therefore the aims of this study were a) to evaluate
the gender differences of the skeletal muscle characteris-
tics in COPD patients b) to explore the gender differences
of the muscle characteristics in healthy subjects and c) to
explore the differences by gender and COPD status in the
skeletal muscle characteristics.
Patients and methods
The study group consisted of 24 women and 30 men with
COPD recruited from the pulmonary clinic of the Hospital
Universitario de Caracas. The control group was formed by
healthy subjects of similar age, 17 women and 9 men The
study was approved by the human-research review board of
the site and all patients and control subjects signed the
informed consent.
We used the definition and severity stratification of COPD
proposed by the Global Initiative for Chronic Lung Disease(GOLD): a ratio of the post-bronchodilator forced expiratory
volume in one second over forced vital capacity (FEV1/FVC)
below 0.7016 and a history of smoking >20 pack-yrs.
Patients were in a clinically stable condition, defined as
no acute exacerbation of COPD for six weeks prior to entry
into the study, and were receiving optimal medical therapy
without regular use of systemic corticosteroids. Patients
were excluded if they had previous diagnosis of asthma,
history of atopy or any other chronic inflammatory illness,
history of malignancy, congestive heart failure, and meta-
bolic diseases, as well as those involved in regular exercise
training. The subjects in the control group had a sedentary
life style and were excluded if they performed regular
exercise.
Pulmonary function test, health status and exercise
capacity
The FEV1, FVC and FEV1/FVC were calculated according to
the recommendations of the ATS.17 Normal values for
pulmonary measurements were taken from a standard
reference source.18 The HRQoL was assessed with the St.
George’s Respiratory Questionnaire (SGRQ), Spanish
version.19,20 Functional capacity was assessed with the six-
minute walking distance (6MWD) and the test was per-
formed following ATS guidelines.21
Skeletal muscle study
All patients and control subjects underwent muscle biop-
sies. Samples were taken from the vastus lateralis part of
the quadriceps femoris muscle, with the Bergstro¨m nee-
dle.22 The muscle sample was divided in two parts, one of
them was embedded with “optimal cutting temperature” or
OCT compound (Tissue Tek II, Sakura Finetek USA Inc.
Torrance CA) and frozen in isopentane cooled in liquid
nitrogen for histochemical analysis, other part was frozen
directly in liquid nitrogen for enzymes determination.
Transverse 10 mm serial sections were cut in a cryostat at
20 C and mounted on cover slips for staining for adeno-
sine triphosphatase (ATPase) after alkaline (pH: 10.3) and
acid (pH: 4.37 and 4.6) preincubation.23 In some patients,
sections were also stained for reduced nicotinamide
adenine dinucleotide diaphorase (NADH-d)24 and a-glycer-
ophosphate dehydrogenase (a-GPD).25 The fibers were
classified as high, medium, or low oxidative activity with
NADH-d, and high, medium and low glycolytic capacity
according to the intensity of the a-GPD staining, evaluated
blindly by two different observers. Capillaries were visu-
alized by the a-amylase-PAS reaction.26 Photomicrographs
at a final magnification of 200 were taken from these
sections and the fibers were identified by comparison with
the ATPase sections. An area of the photograph was
90 S.H. Torres et al.delimited, measured with a planimeter, and fibers and
capillaries were counted to calculate the mean area of the
fibers, capillaries/mm2, and capillaries/fiber ratio. Also,
capillaries around each fiber type were counted and the
mean was expressed as capillary contacts. All the fibers of
one type were drawn together, and the area was measured
by planimetry to calculate the mean cross sectional area
(CSA) of each fiber type. Capillaries per area were calcu-
lated dividing mean capillary contact for a fiber
type  1000 by mean CSA (mm2).
After weighing, the second part of the sample was
homogenized in ice-cooled potassium phosphate buffer.
The activity of citrate synthase (CS), b-hydroxy-acyl-CoA-
dehydrogenase (HAD) and lactate-dehydrogenase (LDH) was
assayed using fluorometric techniques.27 Results are
expressed in mmol min1 g1 wet weight.
Statistical analysis
Data are presented as mean  SD. The differences in the
skeletal muscle characteristics and enzymes activity
between genders in COPD and control subjects were
determined using Student t test. Pearson’s correlation (r)Table 1 Clinical, spirometric, and skeletal muscle histo-
chemical and metabolic characteristics in COPD patients by
gender.
Variables Women
(n Z 24)
Men
(n Z 30)
p-level
Age, years 61  9 65  8 NS
Height, cm 153  7 166  6 <0.00001
Weight, kg 49.8  12.0 65.4  16.1 <0.001
BMI, kg/m2 21.0  4.1 23.4  5.3 NS
FVC, % pred. 74  12 73  17 NS
FEV1, % pred. 49  17 46  19 NS
FEV1/FVC, % 49  8 45  12 NS
SGRQ. Total score 44  17 58  9 NS
6MWD, meter 470  83 448  97 NS
Type I, (%) 42  9 39  13 NS
Type IIA, (%) 38  10 38  9 NS
Type IIX, (%) 19  7 24  10 NS
Mean CSA, mm2 4355  1348 5042  1783 NS
CSA I fibers, mm2 5299  1940 5987  2032 NS
CSA IIA fibers, mm2 4065  1240 4883  2002 NS
CSA IIX fibers, mm2 3488  1229 3754  1846 NS
% area type I fibers 49  8 45  12 NS
% area type IIA fibers 35  8 37  11 NS
% area type IIX fibers 16  7 18  10 NS
Capillaries/mm2 353  119 340  195 NS
Capillaries/fiber
Ratio
1.43  0.4 1.45  0.3 NS
CS, mmol min1 g1 8.59  1.62 9.74  2.61 NS
HAD, mmol min1 g1 9.03  1.85 9.84  2.54 NS
LDH, mmol min1 g1 124  48 151  68 NS
Abbreviations: BMI: Body mass index; FVC: Forced vital
capacity; FEV1: Forced expiratory volume in one minute; SGRQ:
Saint George Respiratory Questionnaire; 6MWD: six-minute
walking distance. CSA: Cross sectional area. CS: Citrate syn-
thase. HAD: b-hydroxy-Acyl-CoA- dehydrogenase. LDH: Lactate
dehydrogenase.was used to assess the relationship between skeletal
muscle characteristics with functional and anthropo-
metric variables. The program used was “Statistica”
(Statsoft, Inc. OK, USA). Acceptable level of statistical
significance for the test was a probability value equal or
less than 0.05.
Results
The clinical, spirometric, and skeletal muscle data of the
COPD subjects by gender are shown in Table 1. Weight and
height were lower in female COPD patients compared to
men. There were no differences in age, body mass index
(BMI), spirometric values (% predicted), 6MWD, and SGRQ
total score between woman and men with COPD. The fiber
type proportion, mean area of the fibers, CSA of each
fiber type, percentage of area occupied by each specific
fiber type, and capillarity (expressed as capillary density
and capillaries per fiber ratio) did not show differences
between the genders in COPD patients. The levels of
oxidative (CS and HAD) and glycolytic (LDH) enzymes were
also similar between men and women with COPD.
The Table 2 shows the anthropometric, pulmonary
function and skeletal muscle characteristics of the control
subjects by gender. Although, the height and weight were
lower in women compared with men, the BMI was similar in
both genders, as well as the spirometric values. ControlTable 2 Anthropometric, spirometric, and skeletal
muscle histochemical and metabolic characteristics in
control subjects by gender.
Variables Women
(n Z 17)
Men
(n Z 9)
p-level
Age, yr 58  8 57  8 NS
Height, cm 153  6 167  14.4 <0.001
Weight, kg 63.1  7.6 73.5  8 <0.05
BMI, kg/m2 26.8  3.5 26.6  4.3 NS
FVC, % predicted 98  10 102  19 NS
FEV1, % predicted 99  10 102  15 NS
FEV1/FVC, % 82  3 81  4 NS
Type I, (%) 54  10 50  14 NS
Type IIA, (%) 36  9 39  14 NS
Type IIX, % 10  5 13  4 NS
Mean CSA, 4893  1628 5967  772 NS
CSA I fibers, mm2 5726  2080 6814  992 NS
CSA IIA fibers, mm2 4689  1660 5903  929 0.08
CSA IIX fibers, mm2 3703  1478 5426  1386 <0.05
% area type I fibers 48  8 46  13 NS
% area type IIA fibers 37  8 40  14 NS
% area type IIX fibers 15  7 14  7 NS
Capillaries/mm2 322  112 288  63 NS
Capillaries/fiber ratio 1.48  0.18 1.69  0.28 0.06
CS, mmol min1 g1 10.5  1.7 11.4  2.2 NS
HAD, mmol min1 g1 10.9  1.8 8.3  3.7 NS
LDH, mmol min1 g1 180  50 197  49 NS
Abbreviations: FVC: Forced vital capacity. FEV1: Forced expi-
ratory volume in one minute. CSA: Cross sectional area. CS:
Citrate synthase. HAD: b-hydroxy-Acyl-CoA- dehydrogenase.
LDH: Lactate dehydrogenase.
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Figure 1 Significant correlations between skeletal muscle
characteristics and anthropometric, spirometric and health
related quality of life parameters in women. FVC: Forced vital
capacity; FEV1: Forced expiratory volume in one minute; SGRQ:
Saint George Respiratory Questionnaire.
15
20
25
30
35
15 25 35 45 55 65
Type I fiber %
I
MB
r = 0.42; p<0.02
2A
20
30
40
50
60
15 25 35 45 55 65
Type I fiber %
l
at
oT
 Q
RGS
r = -0.61; p<0.04
2B
25
35
45
55
0 10 20 30 40 50
Type IIx fiber %
latoT
 
Q
R
GS
r = 0.55; p<0.03
2C
Figure 2 Significant correlations between skeletal muscle
characteristics and anthropometric, spirometric and health
related quality of life parameters in men. BMI: Body mass
index. SGRQ: Saint George Respiratory Questionnaire.
Gender and muscle characteristics in COPD 91women showed significantly lower type IIX fibers CSA,
compared to control men. The mean CSA, type IIA fibers
CSA and capillaries/fiber ratio tended to be smaller in
women compared to men. The other muscle characteristics
were similar in both genders.
Significant correlations between skeletal muscle char-
acteristics with anthropometric and functional parameters
are shown in Figs. 1 and Fig. 2. In COPD women, FEV1 (% of
predicted) and FEV1/FVC directly correlated with type I
fiber proportion (Fig. 1A and B, respectively). In addition,
SGRQ total score inversely correlated with the percentage
of oxidative fibers (Fig. 1C). No other relationships were
observed between skeletal muscle characteristic withanthropometric and functional variables in women with
COPD. There was a direct correlation between the BMI and
type I fibers proportion in men with COPD (Fig. 2A). SGRQ
total score inversely correlated with the percentage of type
I fibers (Fig. 2B), and directly with the percentage of type
IIX fiber (Fig. 2C). No other relationships were observed in
this group.
Skeletal muscle characteristics by gender and COPD
status is shown in Table 3. COPD females compared to
control females had a lower proportion of type I fibers, CS,
HAD and LDH levels. A trend to have a higher proportion of
type IIX fibers was also observed (p Z 0.10). Similar values
were observed in the other muscle characteristics. Men
with COPD had higher proportion of type IIX fibers and
lower CSA of type IIX fibers, compared to control males. No
other differences were observed between men with and
without COPD.
Comparison of skeletal muscle characteristics between
COPD patients and control subjects as a group is shown in
Table 4. COPD patients had lower type I fiber proportion, as
well as percentage of area occupied by type I fibers
Table 3 Skeletal muscle histochemical and metabolic characteristics by gender and COPD condition.
Variables Female Male
COPD (n Z 24) Control (n Z 17) COPD (n Z 30) Control (n Z 9)
Type I, (%) 42  9 48  8* 39  13 50  14
Type IIA, (%) 38  10 37  8 38  9 40  15
Type IIX, (%) 19  7 15  7 24  10 14  3y
Mean CSA, mm2 4355  1348 4893  1628 5042  1783 5967  772
CSA I fibers, mm2 5299  1940 5726  2080 5987  2032 6814  992
CSA IIA fibers, mm2 4065  1240 4689  1660 4883  2002 5903  929
CSA IIX fibers, mm2 3488  1229 3703  1478 3754  1846 5426  1,386y
% area type I fibers 49  8 54  10 45  12 48  14
% area type IIA fibers 35  8 36  9 37  11 39  14
% area type IIX fibers 16  7 10  5 18  10 13  4
Capillaries/mm2 353  119 322  112 340  195 288  63
Capillaries/fiber ratio 1.43  0.4 1.48  0.18 1.45  0.3 1.69  0.28
CS, mmol min1 g1 8.59  1.62 10.51  1.7* 9.74  2.61 11.4  2.2
HAD, mmol min1 g1 9.03  1.85 10.86  1.84* 9.84  2.54 8.3  3.7
LDH, mmol min1 g1 124  48 180  50* 151  68 197  49
*p < 0.05 (female COPD vs. female control).
yp < 0.05 (male COPD vs. male control).
Abbreviations: CSA: Cross sectional area. CS: Citrate synthase. HAD: b-hydroxy-Acyl-CoA- dehydrogenase. LDH: Lactate dehydrogenase.
Table 4 Muscle characteristics in COPD patients and
control subjects as a group.
Variables COPD
(n Z 54)
Control
(n Z 26)
p-level
Type I, % 40  11 47  10 < 0.05
Type IIA, % 38  11 38  10 NS
Type IIX, % 22  9 15  6 <0.001
Mean CSA, mm2 4779  1628 5332  1475 NS
CSA I fibers, mm2 5684  2001 6175  1838 NS
CSA IIA fibers, mm2 4523  1743 5178  1552 NS
CSA IIX fibers, mm2 3634  1589 4331  1687 NS
% area type I fibers 48  10 54  10 <0.05
% area type IIA fibers 36  9 36  9 NS
% area type IIX fibers 17  9 10  5 <0.01
N of capillary
contacts
Type I 4.43  0.86 4.54  0.67 NS
Type IIA 3.59  0.75 3.88  0.83 NS
Type IIX 3.05  0.82 3.41  0.99 NS
Capillary contact/
fiber CSA
Type I 0.76  0.27 0.79  0.25 NS
Type IIA 0.86  0.38 0.81  0.37 NS
Type IIX 0.90  0.51 0.82  0.29 NS
Capillaries/mm2 346  165 314  96 NS
Capillaries/fiber
ratio
1.44  0.3 1.58  0.2 NS
CS, mmol min1 g1 9.07  1.9 10.82  2.0 <0.05
HAD, mmol min1 g1 9.54  2.3 9.82  2.0 NS
LDH, mmol min1 g1 140  61 186  50 <0.05
Abbreviations: BMI: Body mass index; CSA: Cross sectional area.
CS: Citrate synthase. HAD: b-hydroxy-Acyl-CoA- dehydrogenase.
LDH: Lactate dehydrogenase.
92 S.H. Torres et al.compared to controls. COPD patients also had higher
proportion of type IIX fibers and percentage of area occu-
pied by this fiber type. CS and LDH activities were lower in
COPD patients compared to control group. No differences
were observed in HAD activity, fiber CSA and capillarity
between COPD patients and control subjects.Discussion
The skeletal muscles are formed by different proportions of
type I, IIA and IIX fibers. Type I fibers are fatigue resistant,
show slow contraction speed, high oxidative enzymes
activity and high capillary supply; type IIX fibers have low
fatigue resistance, show strong and fast contractions, have
high glycolytic and low oxidative capacity and lower
capillarity; IIA fibers have intermediate properties between
I and IIX fibers. Patients with COPD have a progressive
redistribution of the muscle fibers from type I to type IIX
and reduced oxidative capacity in the vastus lateralis.9,10
The results of the present study indicate that there were
no significant gender differences in the muscle fiber type
distribution, muscle fiber CSA, capillary supply, oxidative
and glycolytic capacity, CS, HAD and LDH enzyme activities
in the quadriceps muscle of patients with COPD. Although
other authors have described gender differences in the
quality of well being and functional capacity in patients
with COPD,2 in the present study COPD patients of both
genders showed similar 6MWD and HRQoL. It is to note that
they were chosen with similar smoking history and severity
of the disease, and the results showed no differences in the
skeletal muscle characteristics. This suggests (but does not
discard) that the clinical differences reported between
women and men are more related to other factors, such as
severity of the disease or exposure to cigarette smoke,
rather than to gender difference in reaction to the disease.
Limited information exists regarding muscle character-
istic in older normal subjects. The results of previous
Gender and muscle characteristics in COPD 93studies indicate that fiber type proportions are similar in
both genders, but fibers CSA are larger in men.12e14 The
findings of the present study are in line with those that
reported no gender differences of fiber type proportion in
healthy subjects12e14; however, partially contrast with
those that found reduction of the CSA of all fibers types in
women, since in our study women only had a significant
reduction in type IIX fiber CSA and a trend in the IIA fiber. In
addition, no gender difference was found in the percentage
of area occupied by type I and IIA fibers. This contrasts with
the findings reported by Marquis et al. in young subjects.6 It
is possible that fiber CSA differences between genders
reduce with aging, probably due to the presence of hypo-
gonadism in men, since testosterone increases fiber size in
healthy young men.28 Hypogonadism has been reported in
about one third of the control male subjects of similar age
to COPD patients.29
A previous report showed that in control subjects, men
have a trend of having higher capillary/fiber ratio
compared to women, and this appears to be related with
fiber size, because disappears when capillaries are
expressed per area of fiber.30 Our results are in agreement
with this finding; after calculating of capillaries expressed
per area of fiber (results not shown) there were not
differences between control men and women.
The lack of gender differences of the skeletal muscle
characteristics in COPD patients could be due to the shift of
fiber types from type I to IIX,10 the decrease of the oxida-
tive capacity of muscle fibers produced by the disease,9 and
the hypogonadism in older men that affects 50% of the
COPD patients.29
Previous studies in COPD patients that include mainly
men showed a reduction in the proportion of type I
fibers9,10,30e32 and, an increase in percentage of IIX
fibers9,30,31 compared with control subjects. Our results are
in agreement with this distribution in COPD patients,
independent of gender. In these patients, reduction of CSA
has been also found in types fibers I, IIa and IIab,30 as well
as in IIX and IIA/IIX fibers compared to normal subjects,33
however, other authors have not found CSA reduction in
the three major fiber types.32
In the present study, lower IIX fiber CSAwas found in male
with COPD compared to control men, whereas no differ-
ences were found in females (COPD vs. control) (Table 3). In
addition, control women showed lower CSA of this type of
fiber compared to control men (Table 2). The discrepancy
observed among the studies could probably be explained by
the differences of the disease severity, patient’s activity
and the percentage of fat free mass of the subjects.
The results of capillary density in COPD patients are
contradictory.30,31 Whittom et al.30 described reduction of
capillary contacts in types I, IIA and IIAB, whereas others
did not find any difference in capillary contacts between
COPD patients and normal subjects.31 The results of the
present study are in agreement with the last report, since
no differences were observed in capillary indexes. These
discrepancies could be due to modification in the size of the
fibers, because they disappeared when capillarity was
expressed as capillaries per area of fiber.30
Reduction of CS and HAD has been found in a group of
COPD patients, mainly composed of men.9 In the present
work this reductionwas found in the females but not inmales(COPD vs. control) (Table 3). Although all patients had
a sedentary way of life, it is possible that differences in
activity could produce changes in the level of the oxidative
enzymes in the muscle. LDH has been reported to be similar
in COPD patients compared to control subjects,9,34 however,
in the presentwork, it decreased slightly, but significantly, in
the female COPD group compared to control female (Table
3); this is an unexpected result, because in a COPD group
studied in the same laboratory, LDH levels were similar
between COPD patients and control subjects.34
In a recent meta-analysis Gosker et al. have assessed
whether vastus lateralis muscle fiber type proportions were
associated with the disease severity and, have provided
reference values for the proportion of fiber types in the
vastus lateralis in COPD.10 Their results indicated that FEV1,
FEV1/FVC ratio and, BMI were directly associated with the
proportion of type I fibers. In the present study, FEV1 (%
pred.) and FEV1/FVC ratio directly correlated with type I
fiber proportion in women with COPD, and in men with
COPD there was a direct relationship between BMI and type
I fiber proportion (Figs. 1 and 2, respectively). The results
suggest that lower airflow obstruction is associated with
a higher proportion of type I fibers which are fundamentally
oxidative. The reason for the gender differences are not
clear and are difficult to explain with the results of the
present study, but could be related with the number of
subjects studied.
In a previous report we have shown that SGRQ (total
score) inversely correlated with type I fiber proportion.5 In
the present study this was confirmed in the male group;
moreover SGRQ (total score) was directly related with type
IIX fiber proportion. Although in female COPD patients, the
SGRQ total score did not correlate with fiber types, this
score was inversely related with the proportion of fiber with
high oxidative capacity (data not shown), indicating that in
general a better HRQoL is associated with the oxidative
capacity of muscle fibers.
Finally there is a limitation in the present study that
needs to be discussed. Due to the invasive nature of
procedure used to obtain the skeletal muscle samples,
a relatively small number of subjects were studied, in
particular male control subjects. It is difficult to find
normal men of comparable age to COPD patients that
adjust to our strict inclusion criteria. However, this
comparison between men and women with COPD and
healthy subjects, appears to be one of the largest number
ever reported of skeletal muscle characteristics.
In conclusion, the vastus lateralis muscle in patients
with COPD has similar characteristics in female and male
subjects; so it seems valid to combine the results of
studies in the vastus lateralis of COPD patients of both
genders. It is possible that the disease blurs the gender
differences. On the other hand, there seems to be fewer
differences in muscle fiber size between older men and
women, perhaps due to the decrease of testosterone in
men. Studies in this direction should be carried out in the
future.Conflict of interest
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